Program

 Program at a glance

To read the PDF file you will need Adobe Reader installed on your computer.

Ⓔ = English Session

Presidential Lecture

Friday, October 11　13:50-14:20 No.1 (Tokyo International Forum Hall C)

Chair:	Yasusada Miura (Professor Emeritus, Jichi Medical University , Japan)
Speaker:	Norio Komatsu (Department of Hematology, Juntendo University Faculty of Medicine, Japan)

Special Lecture

Special Lecture 1

Friday, October 11　14:20-15:10 No.1 (Tokyo International Forum Hall C)

Chair:	Koichi Akashi (Department of Medicine and Biosystemic Science Kyushu University Faculty of Medicine)
Speaker:	Yoshinori Ohsumi (Institute of Innovative Research, Tokyo Institute of Technology, Japan)

Ⓔ Special Lecture 2

Sunday, October 13　13:30-14:20 No.2 (Tokyo International Forum Hall B7(1))

Will Cell Therapy for Hematological Malignancy be a Panacea?

Chair:	Keiya Ozawa (Jichi Medical University)
Speaker:	Malcolm K. Brenner (Center for Cell and Gene Therapy, Baylor College of Medicine, TX, USA)

Ⓔ Special Lecture 3

Sunday, October 13　13:30-14:20 No.3 (Tokyo International Forum Hall B7(2))

Modeling APL pathogenesis through therapy response

Chair:	Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University)
Speaker:	Hugues de Thé (Collège de France, Paris, France)

Ⓔ EHA Special Lecture

Friday, October 11　11:20-12:00 No.1 (Tokyo International Forum Hall C)

High risk JAK-STAT driven acute lymphoblastic leukemia: lessons from Down Syndrome

Chair:	Itaru Matsumura (Depertment of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan)
Speaker:	Shai Izraeli (Schneider Children's Medical Center, Tel Aviv University, Israel)

Ⓔ ASH Special Lecture

Saturday, October 12　11:20-12:00 No.1 (Tokyo International Forum Hall C)

Platelet CD36 at the intersection of inflammation and arterial thrombosis

Chair:	Kuniko Mitani (Department of Hematology and Oncology, Dokkyo Medical University, Japan)
Speaker:	Roy Silverstein (Professor and Chairman, Department of Medicine, Medical College of Wisconsin, WI, USA)

Presidential Symposium

Presidential Symposium 1

Friday, October 11　15:20-17:30 No.1 (Tokyo International Forum Hall C)

AI and medical innovation

Chair:	Arinobu Tojo (The Institute of Medical Science, The University of Tokyo, Japan) Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan)
Speaker:	Kazuyuki Aihara (Institute of Industrial Science, The University of Tokyo, Japan) Kazuaki Yokoyama (Research Hospital, The Institute of Medical Science, The University of Tokyo, Japan) Yoichiro Yamamoto (Pathology Informatics Team, AIP Center, RIKEN, Japan) Akimichi Ohsaka (Juntendo University Graduate School of Medicine, Japan)

Ⓔ Presidential Symposium 2

Saturday, October 12　9:00-11:10 No.1 (Tokyo International Forum Hall C)

A Fascinating Era for Myeloproliferative Neoplasms

Chair:

Norio Komatsu (Department of Hematology, Juntendo University Faculty of Medicine, Japan) Yuzuru Kanakura (Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan)

Speaker:

Robert Kralovics (Principal Investigator, Research Center for Molecular Medicine, CeMM, Austrian Academy of Sciences, Vienna, Austria) Marito Araki (Juntendo University Graduate School of Medicine, Japan) Alessandro Vannucchi (CRIMM, AOU CAREGGI, University of Florence, Firenze, Italy) Jean-Jacques Kiladjian (Centre d'Investigations Cliniques, Paris Diderot University, Paris, France) Ruben Mesa (The UT Health San Antonio MD Anderson Cancer Center, TX, USA)

Ⓔ Asian Joint Panel Discussion

Saturday, October 12　14:50-17:00   No.5 (Tokyo International Forum Hall B5(2))

Epidemiology, diagnosis and treatment of myeloproliferative neoplasms in Asian countries

Chair:

Kazuya Shimoda (University of Miyazaki, Japan) Dong-Tsamn, Lin (National Taiwan University, Taipei, Taiwan)

Speaker:

Zhijian Xiao (Institute of Hematology, Chinese Academy of Medical Sciences) Chien-Chin Lin (Attending Physician, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan) Pongtep Viboonjuntra (Head, Division of Hematology, Department of Medicine, Faculty of Medicine, Prince Songkla University, Songkla, Thailand) Junshik Hong (Seoul National University Hospital) Rabindra Kumar Jena (Dept of Clinical Haematology, SCB Medical College & Hospital) Ong Kiat Hoe (Adjunct Associate Professor, Tang Tok Seng Hospital) Yoko Edahiro (Department of Hematology, Juntendo University)

Symposium

Ⓔ Symposium 1

Friday, October 11　9:00-11:10 No.1 (Tokyo International Forum Hall C)

Molecular pathogenesis of bone marrow failure

Chair:

Toshio Kitamura (The Institute of Medical Science, University of Tokyo, Japan) Atsushi Iwama (The Institute of Medical Science, University of Tokyo, Japan)

Speaker:

Akihide Yoshimi (Memorial Sloan Kettering Cancer Center, New York, USA) Daichi Inoue (Foundation for Biomedical Research and Innovation at Kobe, Japan) Siddhartha Jaiswal (Department of Pathology, Stanford University, CA, USA) Hitoshi Takizawa (International Research Center for Medical Sciences, Kumamoto University, Japan) Marc Raaijmakers (Dept. of Hematology, Erasmus Medical Center cancer Institute, Rotterdam, Netherlands)

Ⓔ Symposium 2

Friday, October 11　9:00-11:10 No.4 (Tokyo International Forum Hall B5(1))

iron metabolism and anemia: an update

Chair:	Takahiro Suzuki (Department of Hematology, Kitasato University School of Medicine, Japan) Katsuya Ikuta (Asahikawa Medical University, Japan)
Speaker:	Masayoshi Kobune (Department of Hematology, Sapporo Medical University) Dorine Swinkels (Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands) Takahiro Kuragano (Hyogo College of Medicine Division of Kidney and Dialysis, Japan) Tohru Fujiwara (Hematology and Rheumatology, Tohoku University Hospital, Japan)

Ⓔ Symposium 3

Friday, October 11　9:00-11:10 No.5 (Tokyo International Forum Hall B5(2))

Perspective on targeted molecular therapy for hematological malignancy in childhood

Chair:

Atsushi Manabe (Department of Pediatrics, St. Luke's International Hospital, Japan) Shouichi Ohga (Graduate School of Medical Sciences, Kyushu University, Japan)

Speaker:

Junko Takita (Department of Pediatrics, University of Kyoto, Japan) Hiroshi Moritake (Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Japan) Kentaro Ohki (Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Japan) Chihaya Imai (Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Japan) Stephen P. Hunger (Children’s Oncology Group, Children’s Hospital of Philadelphia, PA, USA)

Symposium 4

Friday, October 11　15:20-17:30 No.4 (Tokyo International Forum Hall B5(1))

Inhibitors to clotting factors

Chair:	Teruto Hashiguchi (Graduate School of Medical and Dental Sciences, Kagoshima University, Japan) Hidesaku Asakura (Kanazawa University Hospital, Japan)
Speaker:	Nobuaki Suzuki (Nagoya University, Japan) Tazuko Tokugawa (Division of Hematology, Hyogo College of Medicine, Japan) Shinya Yamada (Kanazawa University, Japan) Yoshiyuki Ogawa (Gunma University, Japan) Masaki Hayakawa (Nara Medical University, Japan)

Ⓔ Symposium 5

Friday, October 11　15:20-17:30 No.5 (Tokyo International Forum Hall B5(2))

Germline predisposition to MDS

Chair:	Hironori Harada (Laboratory of Oncology, Department of Medical Science, Tokyo University of Pharmacy and Life Science, Japan) Yasushi Miyazaki (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Japan)
Speaker:	Jean Soulier (Saint-Louis Research Institute, Saint-Louis Hospital and University of Paris, France) Atsushi Manabe (Department of Pediatrics, St. Luke's International Hospital, Japan) Marcin W. Wlodarski (Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN, USA) Motomi Osato (National University of Singapore, Kumamoto University, Japan)

Ⓔ Symposium 6

Saturday, October 12　9:00-11:10 No.5 (Tokyo International Forum Hall B5(2))

Aiming for safer transplants

Chair:

Yoshihiro Inamoto (National Cancer Center Hospital, Japan) Ken-ichi Matsuoka (Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Japan)

Speaker:

Masao Ogata (Department of Hematology, Oita University Hospital, Japan) Michael Boeckh (Head, Infectious Disease Sciences and Member, Vaccine and Infectious Disease Div. nad Clinical Reaesrch Div.; Professor, Dept. of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center and University of Washington, USA) Yasuo Miura (Department of Hematolgy and Oncology, Kyoto University Graduate School of Medicine/Department of Transfusion Medicine and Cell Therapy,Fujita Health University School of Medicine, Japan) Daigo Hashimoto (Department of Hematology, Hokkaido University Faculty of Medicine, Japan) Robert Zeiser (Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg im Breisgau, Germany)

Ⓔ Symposium 7 [JSH-EHA Joint Symposium]

Saturday, October 12　14:50-17:00 No.1 (Tokyo International Forum Hall C)

MRD in AML

Chair:	Shai Izraeli (Schneider Children's Medical Center, Tel Aviv University, Israel) Toshihiro Miyamoto (Kyushu University, Japan)
Speaker:	Gerrit J. Schuurhuis (VU University Medical Center, Amsterdam, Netherlands) Hiroki Yamaguchi (Department of Hematology, Nippon Medical School, Japan) Robert K. Hills (Nuffield Department of Population Health, University of Oxford, UK) Takashi Taga (Shiga University of Medical Science, Japan)

Ⓔ Symposium 8 [JSH-ASH Joint Symposium]

Sunday, October 13　9:00-11:10 No.1 (Tokyo International Forum Hall C)

Recent advances in translational and clinical research in lymphoid malignancies

Chair:	Roy Silverstein (Medical College of Wisconsin, WI, USA) Kunihiro Tsukasaki (International Medical Center, Saitama Medical University, Japan)
Speaker:	David Weinstock (Dana-Farber Cancer Institute and Harvard Medical School, MA, USA) Keisuke Kataoka (National Cancer Center, Japan) Hiroaki Miyoshi (Department of Pathology, Kurume University, School of Medicine, Japan) Kerry J. Savage (BC Cancer, Canada)

Ⓔ Symposium 9

Sunday, October 13　9:00-11:10 No.5 (Tokyo International Forum Hall B5(2))

Progress in tumor immunotherapy

Chair:	Kenzaburo Tani (The Institute of Medical Science, The University of Tokyo, Japan) Yozo Nakazawa (Shinshu University School of Medicine, Japan)
Speaker:	Koji Tamada (Yamaguchi University Graduate School of Medicine, Japan) Takuma Kato (Mie University Graduate School of Medicine, Japan) Alexander Lesokhin (Dept. of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA) Catherine Wu (Dana-Farber Cancer Institute, MA, USA)

Ⓔ Symposium 10

Sunday, October 13　14:30-16:40 No.1 (Tokyo International Forum Hall C)

Novel therapeutic targets on the surface of myeloma cells in association with marrow microenvironment

Chair:

Yusuke Furukawa (Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Japan) Shinsuke Iida (Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan)

Speaker:

Hideto Tamura (Department of Hematology, Nippon Medical School, Japan) Naoki Hosen (Dept of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Japan) James Kochenderfer (Experimental Transplantation and Immunology Dept., National Cancer Institute, NIH, MD, USA) Dirk Hose (Universitatsklinikum Heidelberg, Ruprecht Karls Universitat Heidelberg, Germany) Jiro Kikuchi (Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Japan)

Educational Lecture

Educational Lecture EL1-2A

Friday, October 11　9:00-9:40 No.2 (Tokyo International Forum Hall B7(1))

Advances in multiple myeloma molecular biology research

Chair:	Yasuhito Terui (Department of Hematology Oncology, The Cancer Institute Hospital Of JFCR, Tokyo, Japan)
Speaker:	Ichiro Hanamura (Aichi Medical University, Japan)

Educational Lecture EL1-2B

Friday, October 11　9:45-10:25 No.2 (Tokyo International Forum Hall B7(1))

Current management and emerging treatment strategies for multiple myeloma

Chair:	Kenshi Suzuki (Japanese Red Cross Medical Center)
Speaker:	Noopur Raje (Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA)

Educational Lecture EL1-2C

Friday, October 11　10:30-11:10 No.2 (Tokyo International Forum Hall B7(1))

Management of multiple myeloma in the relapsed/refractory patient

Chair:	Hirokazu Murakami (Gunma University Graduate School of Health Science)
Speaker:	Takayuki Tabayashi (Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan)

Educational Lecture EL1-3A

Friday, October 11　9:00-9:40 No.3 (Tokyo International Forum Hall B7(2))

Treatment of higher risk myelodysplastic syndromes

Chair:	Akihiko Gotoh (Department of Hematology, Tokyo Medical University)
Speaker:	Kensuke Usuki (NTT medical center Tokyo, Japan)

Educational Lecture EL1-3B

Friday, October 11　9:45-10:25 No.3 (Tokyo International Forum Hall B7(2))

Management using the plasma concentration of tyrosine kinase inhibitors for the treatment of chronic myelogenous leukemia: an update

Chair:	Koichi Miyamura (Department of Hematology, Japanese Red Cross Nagoya Daiichi Hospital)
Speaker:	Masatomo Miura (Akita University Hospital, Japan)

Educational Lecture EL1-3C

Friday, October 11　10:30-11:10 No.3 (Tokyo International Forum Hall B7(2))

New therapeutic agents for acute myeloid leukemia

Chair:	Hitoshi Kiyoi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)
Speaker:	Naoko Hosono (Hematology and Oncology, University of Fukui Hospital, Japan)

Educational Lecture EL1-6A

Friday, October 11　9:00-9:40 No.6 (Tokyo International Forum Hall D7)

Translational research for artificial red blood cells (hemoglobin vesicles)

Chair:	Hideo Harigae (Dep. Hematology and Rheumatology, Tohoku University Hospital)
Speaker:	Hiroshi Azuma (Asahikawa Medical University, Japan)

Educational Lecture EL1-6B

Friday, October 11　9:45-10:25 No.6 (Tokyo International Forum Hall D7)

New therapeutic directions on hemophilia

Chair:	Midori Shima (Department of Pediatrics Nara Medical University)
Speaker:	Kagehiro Amano (Department of Laboratory Medicine, Tokyo Medical University)

Educational Lecture EL1-6C

Friday, October 11　10:30-11:10 No.6 (Tokyo International Forum Hall D7)

Onco-cardiology in the field of hematology

Chair:	Masatsugu Ohta (Department of Hematology, Aizu Medical Center, Fukushima Medical University)
Speaker:	Hiroshi Akazawa (Department of Cardiovascular Medicine, The University of Tokyo, Japan)

Educational Lecture EL1-2D

Friday, October 11　15:20-16:00 No.2 (Tokyo International Forum Hall B7(1))

Molecular classification and the clinical relevance in diffuse large B-cell lymphoma

Chair:	Kenichi Ishizawa (Department of Third Internal Medicine, Yamagata University Faculty of Medicine)
Speaker:	Daisuke Ennishi (Okayama University Hospital, Japan)

Educational Lecture EL1-2E

Friday, October 11　16:05-16:45 No.2 (Tokyo International Forum Hall B7(1))

Diffuse large B-cell lymphoma: standard treatment and research questions

Chair:	Hirokazu Nagai (Department of Hematology and Oncology Research Clinical Research Center National Hospital Organization Nagoya Medical Center)
Speaker:	Ken Ohmachi (Tokai University, School of Medicine, Japan)

Educational Lecture EL1-2F

Friday, October 11　16:50-17:30 No.2 (Tokyo International Forum Hall B7(1))

New developments in the treatment of follicular lymphoma

Chair:	Junji Suzumiya (Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, Izumo, Japan)
Speaker:	John Leonard (Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY.)

Educational Lecture EL1-3D

Friday, October 11　15:20-16:00 No.3 (Tokyo International Forum Hall B7(2))

The beneficial effects of iron supplementation other than improvement of anemia

Chair:	Akio Urabe (NTT Medical Center Tokyo)
Speaker:	Takayuki Hamano (Department of Inter-Organ Communication Research in Kidney Disease, Osaka University Graduate School of Medicine, Japan)

Educational Lecture EL1-3E

Friday, October 11　16:05-16:45 No.3 (Tokyo International Forum Hall B7(2))

Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms

Chair:	Shuichi Taniguchi (Department of Hematology, Toranomon Hospital)
Speaker:	Katsuto Takenaka (Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan)

Educational Lecture EL1-3F

Friday, October 11　16:50-17:30 No.3 (Tokyo International Forum Hall B7(2))

Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia

Chair:	Yoshinobu Maeda (Department of Hematology and Oncology, Okayama University Hospital)
Speaker:	Sumiko Kobayashi (Tokyo Metropolitan Gerontorology Hospital, Japan)

Educational Lecture EL1-6D

Friday, October 11　15:20-16:00 No.6 (Tokyo International Forum Hall D7)

Genetic diagnosis of inherited bone marrow failure syndromes

Chair:	Takeshi Inukai (Pediatrics, University of Yamanashi)
Speaker:	Hideki Muramatsu (Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan)

Educational Lecture EL1-6E

Friday, October 11　16:05-16:45 No.6 (Tokyo International Forum Hall D7)

Myeloid proliferations related to Down syndrome

Chair:	Etsuro Ito (Department of Pediatrics, Hirosaki University Graduate School of Medicine)
Speaker:	Daisuke Hasegawa (Department of Pediatrics, St. Luke's International Hospital, Japan)

Educational Lecture EL1-6F

Friday, October 11　16:50-17:30 No.6 (Tokyo International Forum Hall D7)

Status of Langerhans cell histiocytosis in children and adults

Chair:	Masao Kobayashi (Japanese Red Cross, Chugoku-Shikoku Block Blood Center)
Speaker:	Kazuko Kudo (Department of Pediatrics, Fujita Health University, Japan)

Educational Lecture EL2-2A

Saturday, October 12　9:00-9:40 No.2 (Tokyo International Forum Hall B7(1))

Progress in diagnosis and treatment of autoimmune hemolytic anemia

Chair:	Hideho Wada (Department of Hematology, Kawasaki Medical School)
Speaker:	Toyomi Kamesaki (Center for Community Medicine, Jichi Medical University, Japan)

Educational Lecture EL2-2B

Saturday, October 12　9:45-10:25 No.2 (Tokyo International Forum Hall B7(1))

Cereblon as a primary target of IMiDs

Chair:	Naoto Takahashi (Akita Univ. Hematology Nephrology and Rheumatology)
Speaker:	Takumi Ito (Department of Nanoparticle Translational Research, Tokyo Medical University, Japan)

Educational Lecture EL2-2C

Saturday, October 12　10:30-11:10 No.2 (Tokyo International Forum Hall B7(1))

Preservation of fertility in patients with hematologic malignancies

Chair:	Noriko Usui (Div. Clinical Oncol. and Hematology, Dep. Internal Medicine, The Jikei University School of Medicine)
Speaker:	Nobuharu Fujii (Okayama University Hospital, Japan)

Educational Lecture EL2-4A

Saturday, October 12　9:00-9:40 No.4 (Tokyo International Forum Hall B5(1))

Monosomy 7: recent progress

Chair:	Shinji Nakao (Kanazawa University, Institutes of Medical, Pharmaceutical, and Health Science, Division of Medicine, Hematology)
Speaker:	Toshiya Inaba (Hiroshima Univ. Research Institute for Radiation Biology and Medicine, Japan)

Educational Lecture EL2-4B

Saturday, October 12　9:45-10:25 No.4 (Tokyo International Forum Hall B5(1))

Role of HDAC isoforms and development of treatment of multiple myeloma using isoform-specific HDAC inhibitors

Chair:	Masafumi Taniwaki (Center for Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine)
Speaker:	Takeshi Harada (Tokushima University Hospital, Japan)

Educational Lecture EL2-4C

Saturday, October 12　10:30-11:10 No.4 (Tokyo International Forum Hall B5(1))

Current Issues on Research Regulation and Medical Data Protection in Japan

Chair:	Taira Maekawa (Kyoto Prefectural Institute of Public Health and Environment)
Speaker:	Shigeto Yonemura (The University of Tokyo, the Graduate Schools for Law and Politics, Japan)

Educational Lecture EL2-6A

Saturday, October 12　9:00-9:40 No.6 (Tokyo International Forum Hall D7)

Metabolic reprogramming of leukemia cell fate

Chair:	Toshio Suda (International Research Center for Medical Sciences, Kumamoto University, Japan)
Speaker:	Takahiro Ito (University of Georgia, USA)

Educational Lecture EL2-6B

Saturday, October 12　9:45-10:25 No.6 (Tokyo International Forum Hall D7)

Significance and purification of long-term hematopoietic stem cells in the hematopoietic system

Chair:	Hideaki Nakajima (Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine)
Speaker:	Masanori Miyanishi (RIKEN Center for Biosystems Dynamics Research, Japan)

Educational Lecture EL2-6C

Saturday, October 12　10:30-11:10 No.6 (Tokyo International Forum Hall D7)

Cellular senescence and age-related diseases

Chair:	Atsushi Hirao (Division of Molecular Genetics, Kanazawa University, Cancer Research Institute)
Speaker:	Makoto Nakanishi (Division of Cancer Cell Biology, Instuite of Medical Science, University of Tokyo, Japan)

Educational Lecture EL2-2D

Saturday, October 12　14:50-15:30 No.2 (Tokyo International Forum Hall B7(1))

Progress in Immune Checkpoint inhibitor Therapies

Chair:	Masaki Yasukawa (Ehime University Proteo-Science Center)
Speaker:	Yoshiki Akatsuka (Department of Immunology, Graduate School of Medicine, Nagoya University, Japan)

Educational Lecture EL2-2E

Saturday, October 12　15:35-16:15 No.2 (Tokyo International Forum Hall B7(1))

Recent advance in diagnosis and treatment of idiopathic multicentric Castleman disease

Chair:	Mitsune Tanimoto (NHO Iwakuni Clinical Center, Japan)
Speaker:	Shinichiro Okamoto (Department of Hematology, Keio University Hospital, Japan)

Educational Lecture EL2-2F

Saturday, October 12　16:20-17:00 No.2 (Tokyo International Forum Hall B7(1))

Reconstitution of the hematopoietic system and clinical applications of iPS cells

Chair:	Mineo Kurokawa (Department of Hematology and Oncology, The University of Tokyo)
Speaker:	Naoshi Sugimoto (Center for iPS Cell Research and Application, Kyoto University, Japan)

Educational Lecture EL2-4D

Saturday, October 12　14:50-15:30 No.4 (Tokyo International Forum Hall B5(1))

Implications of HLA in allogeneic stem cell transplantation

Chair:	Masahiro Imamura (Department of Hematology, Sapporo Hokuyu Hospital, Japan)
Speaker:	Satoko Morishima (Graduate School of Medicine, University of the Ryukyus, Japan)

Educational Lecture EL2-4E

Saturday, October 12　15:35-16:15 No.4 (Tokyo International Forum Hall B5(1))

Hematopoietic cell transplantation for chronic active EBV infection

Chair:	Ayako Arai (Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine)
Speaker:	Masami Inoue (Osaka Women's and Children's Hospital, Japan)

Educational Lecture EL2-4F

Saturday, October 12　16:20-17:00 No.4 (Tokyo International Forum Hall B5(1))

Management of cytomegalovirus infection after hematopoietic stem cell transplantation

Chair:	Yoshinobu Kanda (Division of Hematology, Saitama Medical Center, Jichi Medical University)
Speaker:	Takehiko Mori (Division of Hematology, Keio University School of Medicine, Japan)

Educational Lecture EL2-6D

Saturday, October 12　14:50-15:30 No.6 (Tokyo International Forum Hall D7)

Lymphomagenesis and Epigenetics

Chair:	Kensei Tobinai (Department of Hematology, National Cancer Center Hospital)
Speaker:	Wendy Béguelin (Division of Hematology/Oncology,Weill Cornell Medical College)

Educational Lecture EL2-6E

Saturday, October 12　15:35-16:15 No.6 (Tokyo International Forum Hall D7)

Exploring the mysteries of megakaryocytopoiesis and thrombopoiesis through comparative hematology

Chair:	Kenichi Sawada (Utsukusigaoka Hospital)
Speaker:	Takashi Kato (Graduate School of Advanced Science and Engineering and Department of Biology, School Of Education, Waseda University, Japan)

Educational Lecture EL2-6F

Saturday, October 12　16:20-17:00 No.6 (Tokyo International Forum Hall D7)

Exosomes in the hematopoietic system

Chair:	Kazuma Ohyashiki (Department of Hematology, Tokyo Medical University, Tokyo, Japan)
Speaker:	Ai Kotani (Tokai University Insitute of Mdeical Science Department of Hamatological Malignancy School of Medicine Department of Hematology and Oncology, Japan)

Educational Lecture EL3-2A

Sunday, October 13　9:00-9:40 No.2 (Tokyo International Forum Hall B7(1))

A role of platelets beyond hemostasis

Chair:	Tsukasa Ohmori (Department of Biochemistry, Jichi Medical University)
Speaker:	Katsue Inoue (Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Japan)

Educational Lecture EL3-2B

Sunday, October 13　9:45-10:25 No.2 (Tokyo International Forum Hall B7(1))

Pregnancy and Labor Management: Women with Venous Thromboembolism or Associated Significant Risk Factors

Chair:	Eriko Morishita (Department of Clinical Laboratory Science, School of Health Sciences, College of Medical Pharmaceutical and Health Sciences, Kanazawa University)
Speaker:	Tomoko Adachi (Aiiku Maternal and Child Health Center, Aiiku Hospital, Japan)

Educational Lecture EL3-2C

Sunday, October 13　10:30-11:10 No.2 (Tokyo International Forum Hall B7(1))

Genome editing in human embryos: ethical concerns and practical applications

Chair:	Kazunori Ohnishi (Tokai-Hokuriku Block Blood Center)
Speaker:	Hidenori Akutsu (National Center for Child Health and Development, Japan)

Educational Lecture EL3-4A

Sunday, October 13　9:00-9:40 No.4 (Tokyo International Forum Hall B5(1))

The 8p11 myeloproliferative syndrome: a review of recent literature

Chair:	Kazuo Dan (Ryotokuji University, Faculty of Health Science)
Speaker:	Keita Kirito (Department of Hematology, University of Yamanashi)

Educational Lecture EL3-4B

Sunday, October 13　9:45-10:25 No.4 (Tokyo International Forum Hall B5(1))

The differential diagnosis of classical myeloproliferative neoplasms (MPN): the updated WHO criteria

Chair:	Masafumi Ito (Department of Pathology, Japanese Red Cross Nagoya Daiichi Hospital)
Speaker:	Hans-Michael Kvasnicka (Institute of Pathology and Molecular Pathology, University Clinic Wuppertal, University Witten-Herdecke, Germany)

Educational Lecture EL3-4C

Sunday, October 13　10:30-11:10 No.4 (Tokyo International Forum Hall B5(1))

Novel treatment strategies for myeloproliferative neoplasms

Chair:	Akiyoshi Takami (Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine)
Speaker:	Srdan Verstovsek (Leukemia Dept., The University of Texas MD Anderson Cancer Center, USA)

Educational Lecture EL3-6A

Sunday, October 13　 9:00-9:40 No.6 (Tokyo International Forum Hall D7)

Progress in single-cell analysis of hematopoiesis

Chair:	Yoshiaki Sonoda (Department of iPS Stem Cell Regenerative Medicine, Kansai Medical University)
Speaker:	Tomohiko Tamura (Department of Immunology, Yokohama City University Graduate School of Medicine)

Educational Lecture EL3-6B

Sunday, October 13　9:45-10:25 No.6 (Tokyo International Forum Hall D7)

Treatment strategy for infants with Acute lymphoblastic leukemia

Chair:	Keizo Horibe (National Hospital Organization Nagoya Medical Centerr, Clinical Research Center)
Speaker:	Takako Miyamura (Department of Pediatrics, Osaka University Graduate School of Medicine, Japan)

Educational Lecture EL3-6C

Sunday, October 13　10:30-11:10 No.6 (Tokyo International Forum Hall D7)

Central Nervous System Involvement in Acute Lymphoblastic Leukemia

Chair:	Kanji Sugita (Yamanashi Blood Center, Japanese Red Cross)
Speaker:	Hisayuki Yao (Department of Cancer Stem Cell and Medicine, Graduate School of Medical Science, Kyushu University, Japan)

Educational Lecture EL3-2D

Sunday, October 13　14:30-15:10 No.2 (Tokyo International Forum Hall B7(1))

Precision medicine in hematological malignancies

Chair:	Seishi Ogawa (Kyoto University Graduate School of Medicine)
Speaker:	Takahiko Yasuda (Nagoya Medical Center, Japan)

Educational Lecture EL3-2E

Sunday, October 13　15:15-15:55 No.2 (Tokyo International Forum Hall B7(1))

Malignant lymphoma: a reappraisal based on PD-L1 expression

Chair:	Jun-ichi Tamaru (Department of Pathology, Saitama Medical Center, Saitama Medical University)
Speaker:	Shigeo Nakamura (Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Japan)

Educational Lecture EL3-2F

Sunday, October 13　16:00-16:40 No.2 (Tokyo International Forum Hall B7(1))

Chimeric antigen receptor T-cell therapy for hematological malignancies

Chair:	Hiroshi Shiku (Department of Imuno-Gene Therapy, Personal Cancer Immunotherapy Mie University Graduate School or Medicine)
Speaker:	Yozo Nakazawa (Shinshu University School of Medicine, Japan)

Educational Lecture EL3-4D

Sunday, October 13　14:30-15:10 No.4 (Tokyo International Forum Hall B5(1))

Gene Therapy for Primary Immunodeficiency

Chair:	Tomohiro Morio (Deparment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University Graduate School of Medicine)
Speaker:	Masafumi Onodera (National Center for Child Health and Development, Japan)

Educational Lecture EL3-4E

Sunday, October 13　15:15-15:55 No.4 (Tokyo International Forum Hall B5(1))

Conflict of interest management in the Japanese Society of Hematology

Chair:	Naoyuki Katayama (Department of Hematology and Oncology, Mie Graduate School of Medicine)
Speaker:	Shigeru Chiba (Department of Hematology, University of Tsukuba, Japan)

Educational Lecture EL3-4F

Sunday, October 13　16:00-16:40 No.4 (Tokyo International Forum Hall B5(1))

To submit, or not to submit.

Chair:	Koiti Inokuchi (Department of Hematology, Nippon Medical School, Tokyo, Japan)
Speaker:	Motohiro Kato (National Center for Child Health and Development, Japan)

Educational Lecture EL3-6D

Sunday, October 13　14:30-15:10 No.6 (Tokyo International Forum Hall D7)

Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers

Chair:	Nobuhiko Emi (National Hospital Organization Toyohashi Medical Center)
Speaker:	Mamiko Sakata-Yanagimoto (University of Tsukuba, Japan)

Educational Lecture EL3-6E

Sunday, October 13　15:15-15:55 No.6 (Tokyo International Forum Hall D7)

The immune microenvironment in malignant lymphoma

Chair:	Shinya Kimura (Div. Hematolgy, Respiratory disease, Oncology, Saga University)
Speaker:	Momoko Nishikori (Department of Hematology and Oncology, Kyoto University, Japan)

Educational Lecture EL3-6F

Sunday, October 13　16:00-16:40 No.6 (Tokyo International Forum Hall D7)

Research achievements and questions on hepatitis B virus reactivation in hematological diseases

Chair:	Junji Tanaka (Department of Hematology Tokyo Women's Medical University)
Speaker:	Masashi Mizokami (National Center for Global Health and Medicine, Japan)

Clinical Debate
A clinical debate between experts. Who do you think has the right answer?
The winner will be decided by your votes!

Clinical Debate 1　malignant lymphoma 1

Saturday, October 12　9:00-10:00 No.3 (Tokyo International Forum Hall B7(2))

･Is early relapse in follicular lymphoma an indication for autologous stem cell transplantation?
･Is treatment necessary for follicular lymphoma relapsing with a low tumor burden?

Chair:	Koji Kato (Kyushu University Hospital, Department of Hematology, Oncology and Cardiovascular medicine, Japan) Kenichi Ishizawa (Department of Third Internal Medicine, Yamagata University Faculty of Medicine, Japan)
Speaker:	Noriko Fukuhara (Tohoku University Hospital, Department of Hematology and Rheumatology, Japan) Kana Miyazaki (Department of Haematology and Oncology, Mie University Graduate School of Medicine, Japan)

Clinical Debate 2　malignant lymphoma 2

Saturday, October 12　10:10-11:10 No.3 (Tokyo International Forum Hall B7(2))

･What is the optimal treatment for DLBCL ending in partial response after R-CHOP therapy: radiation or salvage chemotherapy?
･Is CNS prophylaxis necessary in newly diagnosed DLBCL?

Chair:	Koji Izutsu (National Cancer Center Hospital, Japan)
Speaker:	Wataru Munakata (National Cancer Center Hospital, Japan) Eisei Kondo (Kawasaki Medical School, Japan)

Clinical Debate 3　multiple myeloma 1

Saturday, October 12　14:50-15:50 No.3 (Tokyo International Forum Hall B7(2))

･Treatment strategies for young patients with multiple myeloma: allogeneic stem cell transplantation or CAR-T therapy?

Chair:	Makoto Sasaki (Department of Hematology, Juntendo University, Japan)
Speaker:	Hideto Tamura (Department of Hematology, Nippon Medical School, Japan) Nobuhiro Tsukada (Department of Hematology, Japanese Red Cross Medical Center, Japan)

Clinical Debate 4　multiple myeloma 2

Saturday, October 12　16:00-17:00 No.3 (Tokyo International Forum Hall B7(2))

･Is maintenance therapy necessary in multiple myeloma patients who are MRD-negative after autologous stem cell transplantation?

Chair:	Hirohiko Shibayama (Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan)
Speaker:	Masaki Ri (Division of Blood Transfusion and Cell Therapy, Nagoya City University Hospital, Japan) Tomoki Ito (Kansai Medical University 1st Dept. Internal Medicine, Japan)

Clinical Debate 5　AML

Sunday, October 13　9:00-10:00 No.3 (Tokyo International Forum Hall B7(2))

･FLT3-ITD AML: should allogeneic stem cell transplantation be done at first remission?

Chair:	Hiroki Yamaguchi (Department of Hematology, Nippon Medical School, Japan)
Speaker:	Takashi Toya (Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Japan) Goichi Yoshimoto (Kyushu University Hospital, Hematology, Oncology and Cardiovascular Medicine, Japan)

Clinical Debate 6　MDS

Sunday, October 13　10:10-11:10 No.3 (Tokyo International Forum Hall B7(2))

･Should DNA methylation inhibitors be used in low risk MDS?
･What are the true indications of allogeneic stem cell transplantation in older patients with MDS: who and when?

Chair:	Hironori Harada (Laboratory of Oncology, Department of Medical Science, Tokyo University of Pharmacy and Life Science, Japan)
Speaker:	Masao Hagihara (Eiju General Hospital, Japan) Yuho Najima (Tokyo Metropolitan Komagome Hospital, Japan)

Clinical Debate 7　MPN

Sunday, October 13　14:30-15:30 No.3 (Tokyo International Forum Hall B7(2))

･Treatment of secondary myelofibrosis: medication or transplantation?
･Is pretransplant therapy necessary in advanced stage myelofibrosis?

Chair:	Keita Kirito (Department of Hematology, University of Yamanashi, Japan)
Speaker:	Kazuhiko Ikeda (Department of Blood Transfusion and Transplantation Immunology, Japan) Katsuto Takenaka (Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan)

Clinical Debate 8　CML

Sunday, October 13　15:40-16:40 No.3 (Tokyo International Forum Hall B7(2))

･The CML patient wants to get pregnant. What should the doctor do?
･Is imatinib therapy enough for newly diagnosed elderly CML patients?

Chair:	Takeshi Kondo (Aiiku Hospital, Japan)
Speaker:	Masaya Okada (Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Japan) Tomoiku Takaku (Department of Hematology Juntendo University School of Medicine, Japan) Chikashi Yoshida (National Hospital Organization Mito Medical Center, Japan) Eri Matsuki (Keio University School of Medicine, Japan)

Women Doctors Carrer Symposium

Saturday, October 12　9:30-11:00 No.16 (Tokyo International Forum G405)

Carrer creation for women doctors

Chair:	Kinuko Mitani (Dokkyo Medical University, Department of Hematology and Oncology, Japan) Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University, Japan)
Speaker:	Yasuko Miyahara (Kyoto City Hospital, Japan) Yuiko Tsukada (Tokyo Saiseikai Central Hospital, Japan) Emiko Sakaida (Department of Hematology, Chiba University Hospital, Japan)

Corporate Seminar

Ⓔ Luncheon Seminar　LS1-2

Friday, October 11　12:15-13:00 No.2 (Tokyo International Forum Hall B7(1))

Updates of Blinatumomab for Relapsed or Refractory B-cell Precursor ALL

Sponsor: Amgen Astellas BioPharma K.K. / Astellas Pharma Inc.

Chair:	Yoshinobu Maeda (Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Hematology, Oncology, and Respiratory Medicine)
Speaker:	Jae-Ho Yoon (Catholic Hematology Hospital & Leukemia Research Institute Seoul St. Mary’s Hospital. The Catholic University of Korea, Seoul, Korea)

Luncheon Seminar　LS1-3

Friday, October 11　12:15-13:00 No.3 (Tokyo International Forum Hall B7(2))

Treatment strategies for FLT3 mutated Acute Myeloid Leukemia

Sponsor: DAIICHI SANKYO CO.,LTD.

Chair:	Kazuteru Ohashi (Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan)
Speaker:	Shingo Yano (Clin. Oncol. And Hematol, Jikei University)

Luncheon Seminar　LS1-4

Friday, October 11　12:15-13:00 No.4 (Tokyo International Forum Hall B5(1))

Challenges of CML Therapy and Role of Bosutinib

Sponsor: Pfizer Japan Inc.

Chair:	Shuichi Taniguchi (Toranomon Hospital)
Speaker:	Emiko Sakaida (The Department of Hematology, Chiba University Hospital)

Ⓔ Luncheon Seminar　LS1-5

Friday, October 11　12:15-13:00 No.5 (Tokyo International Forum Hall B5(2))

New genetic predispositions of MDS/AML, what does it change ?

Sponsor: Nippon Shinyaku Co., Ltd.

Chair:	Takayuki Ishikawa (Department of Hematology, Kobe City Medical Center General Hospital)
Speaker:	Jean Soulier (Saint-Louis Hospital and University of Paris, France)

Luncheon Seminar　LS1-6

Friday, October 11　12:15-13:00 No.6 (Tokyo International Forum Hall D7)

Treatment strategy for multiple myeloma; unmet medical need for cases with high risk cytogenetic abnormalities

Sponsor: Takeda Pharmaceutical Company

Chair:	Masahiro Kizaki (Saitama Medical University)
Speaker:	Kazuhito Suzuki (Tokyo Jikeikai Medical Kashiwa Hospital)

Ⓔ Luncheon Seminar　LS1-7

Friday, October 11　12:15-13:00 No.7 (Tokyo International Forum Hall D5)

Evolving Treatment Paradigm for MF and PV

Sponsor: Novartis Pharma K.K.

Chair:	Kazuya Shimoda (Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki)
Speaker:	Ruben Mesa (UT Health San Antonio MD Anderson Cancer Center)

Ⓔ Luncheon Seminar　LS1-8

Friday, October 11　12:15-13:00 No.8 (Tokyo International Forum Hall D1)

Theoretical, practical and clinical aspects of Measurable/Residual Disease (MRD) in acute myeloid leukemia

Sponsor: AbbVie GK

Chair:	Takahiro Maeda (Center for Cellular and Molecular Medicine, Kyushu University Hospital)
Speaker:	Gerrit Jan Schuurhuis (Department of Hematology, Amsterdam University Medical Center, location Vumc, Amsterdam, Netherlands)

Luncheon Seminar　LS1-9

Friday, October 11　12:15-13:00 No.9 (Tokyo International Forum Hall G402)

From the past to present of Total Body Irradiation, and New Evolution by TomoTherapy
~ What a radiation oncologist wants to inform oncologists about ~

Sponsor: Accuray Japan K.K.

Chair:	Keisuke Sasai (Department of Radiation Oncology, Graduate School of Medicine, Juntendo University)
Speaker:	Katsumasa Nakamura (Department of Radiation Oncology, Hamamatsu University School of Medicine)

Luncheon Seminar　LS1-10

Friday, October 11　12:15-13:00 No.10 (Tokyo International Forum Hall G409)

Diagnostic and treatment strategy in the era of quantitative JAK2 V617F detection kit

Sponsor: Sysmex Corporation / Novartis Pharma K.K.

Chair:	Keita Kirito (Department of Hematology/Oncology, University of Yamanashi)
Speaker:	Yuka Sugimoto (Department of Community Hematology, Mie University Graduate School of Medicine)

Luncheon Seminar　LS1-11

Friday, October 11　12:15-13:00 No.11 (Tokyo International Forum Hall G502)

Re-evaluation of Rethio® as high-dose chemotherapy for malignant solid tumors

Sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Chair:	Yoshiyuki Takahashi (Nagoya University Graduate School of Medicine)
Speaker:	Kimikazu Matsumoto (Children's Cancer Center, National Center for Child Health and Development)

Luncheon Seminar　LS1-12

Friday, October 11　12:15-13:00 No.12 (Tokyo International Forum Hall G510)

Oral supportive care for cancer patients with oral mucositis

Sponsor: Meiji Seika Pharma Co., Ltd.

Chair:	Takehiko Mori (Division of Hematology, Department of Medicine Keio University School of Medicine)
Speaker:	Takashi Yurikusa (Division of Dentistry and Oral Surgery Shizuoka Cancer Center Hospital)

Luncheon Seminar　LS1-13

Friday, October 11　12:15-13:00 No.13 (Tokyo International Forum Hall G602)

Paradigm shift in CLL treatment

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Masataka Okamoto (Department of Hematology, Fujita Health University School of Medicine)
Speaker:	Sadao Aoki (Department of Pathophysiology, Niigata University of Pharmacy and Applied Life Sciences)

Luncheon Seminar　LS1-14

Friday, October 11　12:15-13:00 No.14 (Tokyo International Forum Hall G610)

Current topics in the treatment of Ph-positive acute lymphoblastic leukemia

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:	Nobuaki Dobashi (Division of Clinical Oncology and Hematology /The Jikei University Daisan Hospital)
Speaker:	Hirohisa Nakamae (Hematology, Graduate School of Medicine, Osaka City University)

Ⓔ Luncheon Seminar　LS1-15

Friday, October 11　12:15-13:00 No.15 (Tokyo International Forum Hall G701)

How I treat for follicular lymphoma in Real-World Practice

Sponsor: Eisai Co., Ltd / SymBio Pharmaceuticals

Chair:	Junji Suzumiya (Shimane University Hospital Innovative Cancer Center)
Speaker:	Mathias J. Rummel (Clinic for Hematology and Medical Oncology Hospital of the Justus-Liebig-University in Giessen, Germany) Kana Miyazaki (Department of Hematology and Oncology, Mie University Graduate School of Medicine)

Luncheon Seminar　LS1-16

Friday, October 11　12:15-13:00 No.16 (Tokyo International Forum Hall G405)

Treatment goals and outcome measure for hemophilia treatment in the future

Sponsor: Sanofi K.K.

Chair:	Akira Shirahata (University of Occupational and Environmental Health, Japan)
Speaker:	Chiai Nagae (Pediatrics, St. Marianna University School of Medicine. Kanagawa, Japan)

Luncheon Seminar　LS1-17

Friday, October 11　12:15-13:00 No.17 (Tokyo International Forum Hall G407)

Gaucher disease and Hematological diseases

Sponsor: Sanofi K.K.

Chair:	Akira Matsuda (Department of Hemato-Oncology, International Medical Center, Saitama Medical University)
Speaker:	Katsuyuki Kito (Division of Hematology, Department of Internal Medicine, Shiga University of Medical Science) Hiroshi Harada (Department of Hematology, Showa University Fujigaoka Hospital)

Ⓔ Industry Session　IS1-11

Friday, October 11　13:50-14:20 No.11 (Tokyo International Forum Hall G502)

Targeting BCL-2 With BH3 Mimetics: Translating Basic Science to Clinical Application

Sponsor: AbbVie GK

Chair:	Harumi Mukai (AbbVie GK)
Speaker:	Joel D. Leverson (AbbVie Inc.)

Industry Session　IS1-12

Friday, October 11　13:50-14:20 No.12 (Tokyo International Forum Hall G510)

The frontline therapy for PNH
～Next step of terminal complement therapy～

Sponsor: Alexion Pharma GK

Chair:	Kensuke Usuki (NTT Medical Center Tokyo,　Hematology)
Speaker:	Takayuki Ikezoe (Fukushima Medical University, Hematology)

Ⓔ Morning Seminar　MS2-2

Saturday, October 12　7:55-8:40 No.2 (Tokyo International Forum Hall B7(1))

Targeted therapy for AML: a focus upon recently-approved agents.

Sponsor: DAIICHI SANKYO COMPANY, LIMITED

Chair:	Hideaki Nakajima (Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine)
Speaker:	Alexander E. Perl (Associate Professor of Medicine, Division of Hematology/Oncology, University of Pennsylvania; Leukemia Program, Abramson Cancer Center at the University of Pennsylvania)

Morning Seminar　MS2-3

Saturday, October 12　7:55-8:40 No.3 (Tokyo International Forum Hall B7(2))

Therapeutic Strategy 2020 for Multiple Myeloma ~Aiming for deeper responses~

Sponsor: ONO PHARMACEUTICAL CO.,LTD.

Chair:	MASAHIRO ABE (Department of Hematology,Endocrinology and Metabolism, Tokushima University, Japan)
Speaker:	TADAO ISHIDA (Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)

Morning Seminar　MS2-4

Saturday, October 12　7:55-8:40 No.4 (Tokyo International Forum Hall B5(1))

ALL: challenges and new directions

Sponsor: Amgen Astellas BioPharma K.K. Medical Affairs

Chair:	Naoto Takahashi (Department of Hematology, Akita University)
Speaker:	Motohiro Kato (Children’s Cancer Center, National Center for Child Health and Development)

Morning Seminar　MS2-5

Saturday, October 12　7:55-8:40 No.5 (Tokyo International Forum Hall B5(2))

High resolution imaging unveils molecular mechanisms of T cell activation to contribute developing cancer immune therapies.
- Signalosomes constructed by immune-check point and chimeric antigen receptors.-

Sponsor: MSD K.K.

Chair:	Masaki Yasukawa (Ehime University Proteo-Science Center)
Speaker:	Tadashi Yokosuka (Department of Immunology, Tokyo Medical University)

Morning Seminar　MS2-6

Saturday, October 12　7:55-8:40 No.6 (Tokyo International Forum Hall D7)

Current Trends and Issues in the Treatment of Non-Hodgkin Lymphomas

Sponsor: Celgene K.K.

Chair:	Kiyoshi Ando (Department of Hematology and Oncology, Tokai University School of Medicine)
Speaker:	Wataru Munakata (Department of Hematology, National Cancer Center Hospital)

Morning Seminar　MS2-7

Saturday, October 12　7:55-8:40 No.7 (Tokyo International Forum Hall D5)

The new era of hemophilia treatment

Sponsor: CHUGAI PHARMACEUTICAL CO., LTD.

Chair:	Michio Sakai (Pediatrics, MUNAKATA SUIKOKAI GENERAL HOSPITAL)
Speaker:	Nobuaki Suzuki (The Dept of Transfusion medicine, Nagoya Univ. Sch. of Med.)

Ⓔ Morning Seminar　MS2-8

Saturday, October 12　7:55-8:40 No.8 (Tokyo International Forum Hall D1)

Epigenetic basis of B-cell lymphomas

Sponsor: Eisai Co., Ltd. Medical HQs

Chair:	Akifumi Takaori-Kondo (Department of Hematology/Oncology Graduate School of Medicine, Kyoto University)
Speaker:	Wendy Béguelin (Division of Hematology/Oncology,Weill Cornell Medical College)

Morning Seminar　MS2-9

Saturday, October 12　7:55-8:40 No.9 (Tokyo International Forum Hall G402)

Risk management of Tumor lysis syndrome

Sponsor: Sanofi K.K.

Chair:	Kenichi Ishizawa (Department of Third Internal Medicine, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine)
Speaker:	Takahiro Yamauchi (Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui)

Morning Seminar　MS2-10

Saturday, October 12　7:55-8:40 No.10 (Tokyo International Forum Hall G409)

Hodgkin lymphoma: Current progress and future issues

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Shibayama, Hirohiko (Associate Professor, Hematology and Oncology, Division of Medicine, Graduate School of Medicine, Osaka University)
Speaker:	Nishikori, Momoko (Senior Lecturer, Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

Morning Seminar　MS2-11

Saturday, October 12　7:55-8:40 No.11 (Tokyo International Forum Hall G502)

Past, present and future of acute promyelocytic leukemia

Sponsor: Fuji Pharma Co., Ltd.

Chair:	Norio Asou (Department of Hematology International Medical Center Saitama Medical University )
Speaker:	Toru Kiguchi (Department of Hematology, Chugoku Central Hospital)

Morning Seminar　MS2-12

Saturday, October 12　7:55-8:40 No.12 (Tokyo International Forum Hall G510)

Importance of Iron Chelation Therapy in Lower-risk MDS and Scheme to Prevent Overlook

Sponsor: Novartis Pharma K.K.

Chair:	Akihiko Gotoh (Department of Hematology, Tokyo Medical University) Shin Fujisawa (Department of Hematology, Yokohama City University Medical Center)
Speaker:	Yasuyoshi Morita (Division of Hematology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Kindai University) Eisaburo Sueoka (Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University)

Morning Seminar　MS2-13

Saturday, October 12　7:55-8:40 No.13 (Tokyo International Forum Hall G602)

Autoimmune hemolytic anemia (AIHA)　–Revision of Guideline and Risk of Thromboembolism-

Sponsor: Sanofi K.K.

Chair:	Hideo Harigae　 (Hematology and Rheumatology, Tohoku University, Graduate School of Medicine)
Speaker:	Toyomi Kamesaki (Division of Support in Community Medicine, Center for Community Medicine, Jichi Medical University)

Morning Seminar　MS2-14

Saturday, October 12　7:55-8:40 No.14 (Tokyo International Forum Hall G610)

How to utilize Factor VIII therapy in Hemophilia A

Sponsor: Bayer Yakuhin, Ltd.

Chair:	Masashi Taki (Department of Pediatrics, St.Marianna University School of Medicine)
Speaker:	Makoto Kaneda (Department of pediatrics and hemophilia treatment center in Sapporo Tokusyukai Hospital)

Morning Seminar　MS2-15

Saturday, October 12　7:55-8:40 No.15 (Tokyo International Forum Hall G701)

Molecular abnormalities in chronic lymphocytic leukemia and mantle cell lymphoma: p53 abnormalities and implications for therapy

Sponsor: Janssen Pharmaceutical K.K., Medical Affairs Division

Chair:	Yasuhito Terui (Director of Hematology Oncology, Cancer Institute Hospital Hematology, JAPANESE FOUNDATION FOR CANCER RESEACH)
Speaker:	Kensuke Kojima (Professor, Department of Hematology, Kochi University)

Ⓔ Luncheon Seminar　LS2-2

Saturday, October 12　12:15-13:00 No.2 (Tokyo International Forum Hall B7(1))

Treatment Strategies for Tlansplant Ineligible Newly Diagnosed Multiple Myeloma

Sponsor: Celgene K.K.

Chair:	Yasushi Takamatsu (Professor of Department of Medical Oncology, Hematology and Infectious Diseases at Fukuoka University Hospital)
Speaker:	Noopur Raje (Professor of Medicine at Harvard Medical School/ Director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center, USA)

Ⓔ Luncheon Seminar　LS2-3

Saturday, October 12　12:15-13:00 No.3 (Tokyo International Forum Hall B7(2))

Multiple Myeloma at the Cutting Edge: What are the CHALLENGES we face today in our clinical practice?

Sponsor: Janssen Pharmaceutical K.K.

Chair:	Kenji Ishitsuka (Department of Hematology and Pheumatology kagoshima University Department of Hematology and Rheumatology kagoshima University Hospital)
Speaker:	Nizar J. Bahlis (Charbonneau Cancer Research Institute, University of Calgary)

Ⓔ Luncheon Seminar　LS2-4

Saturday, October 12　12:15-13:00 No.4 (Tokyo International Forum Hall B5(1))

Optimal therapeutic strategies in follicular lymphoma

Sponsor: Chugai Pharmaceutical Co., Ltd. / Nippon Shinyaku Co., Ltd

Chair:	Kazuhito Yamamoto (Department of Hematology and Cell Therapy, Aichi Cancer Center)
Speaker:	Miguel Canales (The Section Chief of Haematology ,Hospital la Paz, Madrid, Spain)

Luncheon Seminar　LS2-5

Saturday, October 12　12:15-13:00 No.5 (Tokyo International Forum Hall B5(2))

Current Status and Future of CML treatment

Sponsor: Bristol-Myers Squibb K.K.

Chair:	Koichi Akashi (Department of Medicine and Biosystemic Science, Graduate School of Medical Science, Kyushu University)
Speaker:	Itaru Matsumura (Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine)

Luncheon Seminar　LS2-6

Saturday, October 12　12:15-13:00 No.6 (Tokyo International Forum Hall D7)

Treatment strategy for Diffuse large B-cell lymphoma

Sponsor: Kyowa Kirin Co., Ltd.

Chair:	Hirokazu Nagai (National Hospital Organization Nagoya Medical Center)
Speaker:	Ken Ohmachi (Tokai University, school of medicine, internal medicine, division of hematology/oncology)

Luncheon Seminar　LS2-7

Saturday, October 12　12:15-13:00 No.7 (Tokyo International Forum Hall D5)

How We Treat ITP in New Era? ~ Key Points of the Revised Reference Guide

Sponsor: Novartis Pharma K.K.

Chair:	Takayuki Ikezoe (Department of Hematology, Fukushima Medical University)
Speaker:	Takaaki Hato (Department of Blood Transfusion and Cell Therapy, Ehime University Graduate School of Medicine)

Luncheon Seminar　LS2-8

Saturday, October 12　12:15-13:00 No.8 (Tokyo International Forum Hall D1)

Opening new era of PNH（paroxysmal nocturnal hemoglobinuria）
- Encounter with the first and only long-acting C5 inhibitor ‘Ultomiris®’and ‘Attention!’-

Sponsor: Alexion Pharma GK

Chair:	Kinuko Mitani (Department of Hematology and Oncology, Dokkyo Medical University School of Medicine)
Speaker:	Junichi Nishimura (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Ⓔ Luncheon Seminar　LS2-9

Saturday, October 12　12:15-13:00 No.9 (Tokyo International Forum Hall G402)

Mutational landscape in MPN: towards personalized therapy

Sponsor: PharmaEssentia Japan KK

Chair:	Yuzuru Kanakura (Sumitomo Hospital)
Speaker:	Robert Kralovics (CeMM-Center for Molecular Medicine of the Austrian Academy of Science Vienna, Austria)

Ⓔ Luncheon Seminar　LS2-10

Saturday, October 12　12:15-13:00 No.10 (Tokyo International Forum Hall G409)

Open questions in the management of follicular lymphoma

Sponsor: Eisai Co., Ltd / SymBio Pharmaceuticals

Chair:	Koji Izutsu (Department of Hematology, National Cancer Center Hospital)
Speaker:	Michele Ghielmini (Oncology Institute of Southern Switzerland in Bellinzona)

Ⓔ Luncheon Seminar　LS2-11

Saturday, October 12　12:15-13:00 No.11 (Tokyo International Forum Hall G502)

The WHO classification of MPN – updates in morphology and molecular findings

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Masafumi Ito (Japanese Red Cross Nagoya Daiichi Hospital)
Speaker:	Hans Michael Kvasnicka (University of Frankfurt)

Luncheon Seminar　LS2-12

Saturday, October 12　12:15-13:00 No.12 (Tokyo International Forum Hall G510)

Thinking about haemophilia treatment from the factor IX modification technology and their mode of action.

Sponsor: Novo Nordisk Pharma Ltd.

Chair:	Shima Midori (Department of Pediatrics Nara Medical University)
Speaker:	Nogami Keiji (Department of Pediatrics Nara Medical University)

Ⓔ Luncheon Seminar　LS2-13

Saturday, October 12　12:15-13:00 No.13 (Tokyo International Forum Hall G602)

Modeling Plasma Cell Microenvironment Interactions to Improve Clinical Decision Making in Multiple Myeloma.

Sponsor: Fujimoto Pharmaceutical Corporation

Chair:	Kazuyuki Shimizu (Higashinagoya National Hospital)
Speaker:	Gareth J Morgan (New York University Langone Medical Center, Perlmutter Cancer Center. New York.)

Luncheon Seminar　LS2-14

Saturday, October 12　12:15-13:00 No.14 (Tokyo International Forum Hall G610)

Novel agents and strategies in PTCL

Sponsor: Mundipharma K.K.

Chair:	Eisei KONDO (Division of Hematology, Department of Medicine, Kawasaki Medical School)
Speaker:	Shinya RAI (Department of Hematology and Rheumatology, Kindai University Faculty of Medicine)

Luncheon Seminar　LS2-15

Saturday, October 12　12:15-13:00 No.15 (Tokyo International Forum Hall G701)

CML －Road to Treatment-free Remission－

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:	Tetsuya Fukuda (Department of Hematology, Tottori University Hospital)
Speaker:	Koji Sasaki (Department of Leukemia, The University of Texas MD Anderson Cancer Center)

Luncheon Seminar　LS2-16

Saturday, October 12　12:15-13:00 No.16 (Tokyo International Forum Hall G405)

Management of secondary hypogammaglobulinemia in hematological malignancies

Sponsor: CSL Behring K.K.

Chair:	Tatsuo Ichinohe (Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University)
Speaker:	Hitoshi Hanamoto (Department of Hematology, Kindai University Nara Hospital) Shigeo Fuji (Department of Hematology, Osaka International Cancer Institute, Osaka, Japan)

Luncheon Seminar　LS2-17

Saturday, October 12　12:15-13:00 No.17 (Tokyo International Forum Hall G407)

Clinical usefulness of Voriconazole's TDM for invasive fungal infections

Sponsor: Pfizer Japan Inc.

Chair:	Satoshi Takahashi (Hematology and Oncology, The University of Tokyo, The Institute of Medical Science)
TDM of Voriconazole : Pharmaceutical approach
Speaker:	Satohiro Masuda (Department of Pharmacy, Narita Hospital International University of Health and Welfare)
Optimization of antifungal prophylaxis and treatment by TDM
Speaker:	Yasushi Onishi (Department of Hematology and Rheumatology, Tohoku University Hospital)

Ⓔ Morning Seminar　MS3-2

Sunday, October 13　7:55-8:40 No.2 (Tokyo International Forum Hall B7(1))

Treatment Strategy for Relapse and Refractory Multiple Myeloma and Role of Pomalidomide

Sponsor: Celgene K.K.

Chair:	Shinsuke Iida (Professor of Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences)
Speaker:	Noopur Raje (Professor of Medicine at Harvard Medical School/ Director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center, USA)

Morning Seminar　MS3-3

Sunday, October 13　7:55-8:40 No.3 (Tokyo International Forum Hall B7(2))

Treatment of chronic myeloid leukemia, Now and Future -Focus on current evidence and practice of Treatment-Free Remission-

Sponsor: Novartis Pharma K.K.

Chair:	Shinya Kimura (Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University)
Speaker:	Eri Matsuki (Keio University School of Medicine, Department of Medicine, Division of Hematology)

Morning Seminar　MS3-4

Sunday, October 13　7:55-8:40 No.4 (Tokyo International Forum Hall B5(1))

Management of Hepatitis B Virus Reactivation during and/or following Immunosuppressive Therapies and Chemotherapies　

Sponsor: Gilead Sciences K.K.

Chair:	Yoshinobu Kanda (Division of Hematology, Department of Medicine, Jichi Medical University/Division of Hematology, Jichi Medical University Saitama Medical Center)
Speaker:	Satoshi Mochida (Department of Hepatology & Gastroenterology, Faculty of Medicine, Saitama Medical University)

Morning Seminar　MS3-5

Sunday, October 13　7:55-8:40 No.5 (Tokyo International Forum Hall B5(2))

Optimal treatment with newer agents for relapsed and refractory multiple myeloma

Sponsor: Bristol-Myers Squibb K.K.

Chair:	Toshihiro Miyamoto (Department of Medicine and Biosystemic Science, Kyusyu University Graduate School of Medical Science)
Speaker:	Shigeki Ito (Hematology & Oncology, Department of Internal Medicine , Iwate Medical University School of Medicine)

Morning Seminar　MS3-6

Sunday, October 13　7:55-8:40 No.6 (Tokyo International Forum Hall D7)

The future of the genome practice in the hematologic malignancies

Sponsor: Astellas Pharma Inc. Medical Affairs

Chair:	Seishi Ogawa (Professor, Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan)
Speaker:	Keisuke Kataoka (Chief, Division of Molecular Oncology, National Cancer Center Research Institute, Japan)

Morning Seminar　MS3-7

Sunday, October 13　7:55-8:40 No.7 (Tokyo International Forum Hall D5)

What should we check to achieve zero bleed with hemophilia B

Sponsor: CSL Behring K.K.

Chair:	Kagehiro Amano (Department of Laboratory Medicine, Tokyo Medical University)
Speaker:	Teruhisa Fujii (Division of Blood Transfusion, Hiroshima University Hospital)

Morning Seminar　MS3-8

Sunday, October 13　7:55-8:40 No.8 (Tokyo International Forum Hall D1)

Risk of Hepatitis B virus reactivation in patients with hematological malignancies

Sponsor: Zenyaku Kogyo Co., Ltd.

Chair:	Yasuhito Tanaka (Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences)
Speaker:	Shigeru Kusumoto (Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences)

Morning Seminar　MS3-9

Sunday, October 13　7:55-8:40 No.9 (Tokyo International Forum Hall G402)

Prognostic Impact of WT1 mRNA in AML Patients: Overview and Future Perspectives.

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:	Koiti Inokuchi (Department of Hematology, Nippon Medical School)
Speaker:	Akira Shimada (Department of Pediatric Hematology/Oncology, Okayama University Hospital) Yasunori Ueda (Department of Hematology/Oncology, Kurashiki Central Hospital)

Morning Seminar　MS3-10

Sunday, October 13　7:55-8:40 No.10 (Tokyo International Forum Hall G409)

Management of infectious complications in the treatment of hematologic malignancies

Sponsor: SHIONOGI & CO., LTD.

Chair:	Tsuyoshi Nakamaki (Division of Hematology Department of Medicine Showa University School of Medicine)
Speaker:	Nobu Akiyama (Department of Internal Medicine, Teikyo University School of Medicine)

Morning Seminar　MS3-11

Sunday, October 13　7:55-8:40 No.11 (Tokyo International Forum Hall G502)

Examine the medical economy of DIC complicated with acute leukemia

Sponsor: Asahi　Kasei　Pharma　Corporation

Chair:	Shosaku Nomura (First Department of Internal Medicine，KANSAI MEDICAL UNIVERSITY)
Speaker:	Naoki Takezako (Department of Hematology，National Hospital Organization Disaster Medical Center of Japan)

Morning Seminar　MS3-12

Sunday, October 13　7:55-8:40 No.12 (Tokyo International Forum Hall G510)

Genetic mechanism targeting immune microenvironment and the therapeutics of DLBCL

Sponsor: AstraZeneca K.K.

Chair:	Masahiro Yokoyama (Division of Hematology Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research)
Speaker:	Daisuke Ennishi (Department of Hematology and Oncology, Okayama University Hospital)

Morning Seminar　MS3-13

Sunday, October 13　7:55-8:40 No.13 (Tokyo International Forum Hall G602)

G-CSF:From its discovery to today

Sponsor: MOCHIDA PHARMACEUTICAL CO.,LTD.

Chair:	Shinichiro Okamoto (Division of Hematology Keio University Hospital)
Speaker:	Mitsune Tanimoto (NHO Iwakuni Clinical Center)

Morning Seminar　MS3-14

Sunday, October 13　7:55-8:40 No.14 (Tokyo International Forum Hall G610)

Essential Role of Factor VIII therapy for Hemophilia A

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Yasuharu Nishida (Division of Infectious Disease, Osaka National Hospital)
Speaker:	Yushi Chikasawa (Department of Laboratory Medicine, Tokyo Medical University)

Morning Seminar　MS3-15

Sunday, October 13　7:55-8:40 No.15 (Tokyo International Forum Hall G701)

Fungal infections in patients with hematological malignancy -Risk and Pitfall-

Sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Chair:	Yasushi Miyazaki (Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University)
Speaker:	Junichiro Yuda (Department of Hematology, National Cancer Center Hospital East)

Luncheon Seminar　LS3-1

Sunday, October 13　12:25-13:10 No.1 (Tokyo International Forum Hall C)

New Treatment Option for refractory/relapse DLBCL ‐CAR-T cell therapy‐

Sponsor: Novartis Pharma K.K.

Chair:	Keiya Ozawa (Division of Immuno-Gene & Cell therapy (Takara Bio), Jichi Medical University)
Speaker:	Takanori Teshima (Hokkaido University Hospital Department of Hematology)

Ⓔ Luncheon Seminar　LS3-2

Sunday, October 13　12:25-13:10 No.2 (Tokyo International Forum Hall B7(1))

Disease characteristics and future treatment perspective for indolent NHL

Sponsor: Celgene K.K. Medical Affairs

Chair:	Kiyohiko Hatake (Department of Hematology, International University of Health and Welfare(IUHW), School of Medicine, Lymproma/Hematology center, IUHW Mita Hospital)
Speaker:	John P. Leonard (Division of Hematology/Oncology, Weill Medical College of Cornell University)

Ⓔ Luncheon Seminar　LS3-3

Sunday, October 13　12:25-13:10 No.3 (Tokyo International Forum Hall B7(2))

The Emerging Role of FLT3 inhibition in AML therapy

Sponsor: Astellas Pharma Inc.

Chair:	Hitoshi Kiyoi (Nagoya University Graduate School of Medicine Department of Hematology and Oncology)
Speaker:	Alexander E. Perl (Associate Professor of Medicine, Division of Hematology/Oncology, University of Pennsylvania; Leukemia Program, Abramson Cancer Center at the University of Pennsylvania)

Luncheon Seminar　LS3-4

Sunday, October 13　12:25-13:10 No.4 (Tokyo International Forum Hall B5(1))

Current practice and future prospects of R/R ALL treatment with Inotuzumab Ozogamicin

Sponsor: Pfizer Japan Inc.

Chair:	Masayuki Hino (Department of Hematology, Osaka City University)
Speaker:	Yuho Najima (Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital)

Luncheon Seminar　LS3-5

Sunday, October 13　12:25-13:10 No.5 (Tokyo International Forum Hall B5(2))

PD-1 Blockade Therapy for Hodgkin Lymphoma

Sponsor: ONO PHARMACEUTICAL CO., LTD./Bristol-Myers Squibb K.K.

Chair:	Akihiro Tomita (Professor, Department of Hematology, Fujita Health University School of Medicine)
Speaker:	Noriko Fukuhara (Department of Hematology and Rheumatology, Tohoku University Hospital)

Luncheon Seminar　LS3-6

Sunday, October 13　12:25-13:10 No.6 (Tokyo International Forum Hall D7)

Treatment strategy for aplastic anemia
～Clinical results of Romiplostim for aplastic anemia～

Sponsor: Kyowa Kirin Co., Ltd.

Chair:	Shinji Nakao (Hematology, Division of Medicine, Institutes of Medical, Pharmaceutical, and Health Science, Kanazawa University)
Speaker:	Koji Nagafuji (Division of Hematology and Oncology, Department of Medicine Kurume University School of Medicine)

Ⓔ Luncheon Seminar　LS3-7

Sunday, October 13　12:25-13:10 No.7 (Tokyo International Forum Hall D5)

Practical management of MPNs

Sponsor: PharmaEssentia Japan KK

Chair:	Kensuke Usuki (NTT Medical Center Tokyo)
Speaker:	Jean-Jacques Kiladjian (Centre d'Investigations Cliniques, Paris Diderot University, Paris, France)

Luncheon Seminar　LS3-8

Sunday, October 13　12:25-13:10 No.8 (Tokyo International Forum Hall D1)

Clinical questions of treatment for follicular lymphoma

Sponsor: Eisai Co., Ltd / SymBio Pharmaceuticals

Chair:	Norifumi Tsukamoto (Department of Oncology Center, Gunma University Hospital, Gunma)
Speaker:	Dai Maruyama (Department of Hematology, National Cancer Center Hospital)

Ⓔ Luncheon Seminar　LS3-9

Sunday, October 13　12:25-13:10 No.9 (Tokyo International Forum Hall G402)

CURRENT MANAGEMENT OF ESSENTIAL THROMBOCYTHEMIA IN YOUNG SUBJECTS

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Katsuto Takenaka (Department of Hematology, Ehime University Hospital)
Speaker:	Alessandro M. Vannucchi (University of Florence)

Luncheon Seminar　LS3-10

Sunday, October 13　12:25-13:10 No.10 (Tokyo International Forum Hall G409)

Treatment strategies for newly diagnosed transplant ineligible multiple myeloma

Sponsor: Janssen Pharmaceutical K.K., Medical Affairs Division

Chair:	Junya Kuroda (Division of Hematology and Oncology, Kyoto Prefectural University of Medicine)
Speaker:	Tomoaki Fujisaki (Department of Internal Medicine, Matsuyama Red-Cross Hospital)

Luncheon Seminar　LS3-11

Sunday, October 13　12:25-13:10 No.11 (Tokyo International Forum Hall G502)

Treatment strategy for break through bleeding during prophylactic therapy in hemophilia patients

Sponsor: CSL Behring K.K.

Chair:	Tadashi Matsushita (Nagoya University Hospital Professor Department of Transfusion Medicine)
Speaker:	Masahiro Takeyama (Department of Pediatrics, Nara Medical University)

Luncheon Seminar　LS3-12

Sunday, October 13　12:25-13:10 No.12 (Tokyo International Forum Hall G510)

Update in management of infection for hematological malignancy patient

Sponsor: MSD K.K.

Chair:	Junji Tanaka (Department of Hematology, Tokyo Women's Medical University)
Speaker:	Michihiro Uchiyama (Director Department of Hematology,Suwa Red Cross Hospital) Shinichiro Mori (Director Department of Hematology, St. Luke’s International Hospital)

Luncheon Seminar　LS3-13

Sunday, October 13　12:25-13:10 No.13 (Tokyo International Forum Hall G602)

Autologous stem cell transplantation by Plerixafor

Sponsor: Sanofi K.K.

Chair:	Sunami Kazutaka (Department of Hematology, National Hospital Organization Okayama Medical Center)
Speaker:	Sawa Masashi (Department of Hematology and Oncology, Anjo Kosei Hospital) Masako Toyosaki (Department of Hematology and Oncology, School of Medicine, Tokai University)

Luncheon Seminar　LS3-14

Sunday, October 13　12:25-13:10 No.14 (Tokyo International Forum Hall G610)

Reconsideration of the therapeutic concept for mature lymphoid malignancy

Sponsor: AbbVie GK

Chair:	Jun Takizawa (Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine)
Speaker:	Koji Kato (Kyushu University Hospital Hematology, Oncology & Cardiovascular medicine)

Luncheon Seminar　LS3-15

Sunday, October 13　12:25-13:10 No.15 (Tokyo International Forum Hall G701)

Continuous therapy for multiple myeloma

Sponsor: Takeda Pharmaceutical Company Limited

Chair:	Hiroshi Handa (Department of Hematology, Gunma University Graduate School of Medicine)
Speaker:	Makoto Sasaki (Department of Hematology, Juntendo University School of Medicine)